Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AMTX
|
Francis P Barton |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 59.79% |
$182,000
$9.1 p/Share
|
Jan 26
2021 |
|
AMTX
|
Andrew B Foster
Executive Vice President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 48.85% |
$45,200
$9.04 p/Share
|
Jan 26
2021 |
|
AMTX
|
Todd Waltz
Executive Vice President, CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.7% |
$96,100
$9.61 p/Share
|
Jan 26
2021 |
|
MSGE
|
Leinauer Corby Dolan
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 164 Reduced 0.0% |
$15,927
$97.12 p/Share
|
Jan 26
2021 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$18,773,528
$328.22 p/Share
|
Jan 26
2021 |
|
RVLV
|
David Pujades
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 7,600 Reduced 100.0% |
$302,328
$39.78 p/Share
|
Jan 26
2021 |
|
NPTN
|
Chiyue Cheung
COO |
SELL
Open market or private sale
|
Direct | 19,500 Reduced 100.0% |
$230,490
$11.82 p/Share
|
Jan 26
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.7% |
$241,800
$8.06 p/Share
|
Jan 26
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.7% |
$241,800
$8.06 p/Share
|
Jan 26
2021 |
|
RLMD
|
Paul Edward Kelly
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 685 Reduced 0.46% |
$24,085
$35.16 p/Share
|
Jan 26
2021 |
|
RLMD
|
Sergio Traversa
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 0.79% |
$21,090
$35.15 p/Share
|
Jan 26
2021 |
|
RLMD
|
Maged Shenouda
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 607 Reduced 21.41% |
$21,342
$35.16 p/Share
|
Jan 26
2021 |
|
REAL
|
Levesque Rati Sahi
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,629 Reduced 0.85% |
$42,191
$25.9 p/Share
|
Jan 26
2021 |
|
MDLA
|
Leslie Stretch
President and CEO |
SELL
Open market or private sale
|
Direct | 179,500 Reduced 13.21% |
$8,091,860
$45.08 p/Share
|
Jan 26
2021 |
|
CRIS
|
James E Dentzer
President & CEO |
SELL
Open market or private sale
|
Direct | 3,094 Reduced 4.4% |
$32,765
$10.59 p/Share
|
Jan 26
2021 |
|
UAMY
|
Kenneth M Reed
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 540,275 Reduced 56.26% |
$529,470
$0.98 p/Share
|
Jan 26
2021 |
|
URGN
|
Mark Schoenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.5% |
$2,212
$22.12 p/Share
|
Jan 26
2021 |
|
MDLA
|
Stanley J Meresman
Director |
SELL
Open market or private sale
|
Indirect | 160,000 Reduced 100.0% |
$6,716,800
$41.98 p/Share
|
Jan 26
2021 |
|
LEGH
|
Curtis Drew Hodgson
Director |
SELL
Open market or private sale
|
Indirect | 1,211 Reduced 0.04% |
$18,649
$15.4 p/Share
|
Jan 26
2021 |
|
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 18,142 Reduced 0.5% |
$465,887
$25.68 p/Share
|
Jan 26
2021 |
|
GTE
|
Gmt Capital Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 38,500 Reduced 0.06% |
$18,480
$0.48 p/Share
|
Jan 26
2021 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 1,363 Reduced 0.03% |
$28,732
$21.08 p/Share
|
Jan 26
2021 |
|
CWH
|
Crestview Partners Ii Gp, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 235,543 Reduced 2.63% |
$8,889,393
$37.74 p/Share
|
Jan 26
2021 |
|
TRV
|
William H Heyman
Vice Chairman |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 1.24% |
$441,750
$147.25 p/Share
|
Jan 26
2021 |
|
DELL
|
Jeffrey W Clarke
COO & Vice Chairman |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 20.64% |
$7,591,000
$75.91 p/Share
|
Jan 26
2021 |
|
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 14,400 Reduced 0.16% |
$956,448
$66.42 p/Share
|
Jan 26
2021 |
|
PPL
|
Joanne H Raphael
EVP, GC & Corp Sec |
SELL
Open market or private sale
|
Direct | 4,589 Reduced 8.97% |
$129,043
$28.12 p/Share
|
Jan 26
2021 |
|
PPL
|
Gregory N Dudkin
Executive Vice President |
SELL
Open market or private sale
|
Direct | 4,747 Reduced 11.47% |
$133,486
$28.12 p/Share
|
Jan 26
2021 |
|
NBIX
|
Gary A Lyons
Director |
SELL
Open market or private sale
|
Direct | 400 Reduced 0.18% |
$48,000
$120.0 p/Share
|
Jan 26
2021 |
|
NBIX
|
Malcolm Lloyd Smith
Chief Integration Officer |
SELL
Open market or private sale
|
Direct | 1,100 Reduced 3.65% |
$131,967
$119.97 p/Share
|
Jan 26
2021 |
|
NBIX
|
Eric Benevich
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 400 Reduced 2.48% |
$48,000
$120.0 p/Share
|
Jan 26
2021 |
|
CBSH
|
Jonathan M Kemper
Director |
SELL
Open market or private sale
|
Direct | 6,877 Reduced 0.76% |
$475,063
$69.08 p/Share
|
Jan 26
2021 |
|
BE
|
Swaminathan Venkataraman
EVP of Engineering & CTO |
SELL
Open market or private sale
|
Direct | 11,499 Reduced 6.89% |
$447,541
$38.92 p/Share
|
Jan 26
2021 |
|
BE
|
Susan Seilheimer Brennan
EVP & COO |
SELL
Open market or private sale
|
Direct | 4,664 Reduced 2.1% |
$181,336
$38.88 p/Share
|
Jan 26
2021 |
|
CVET
|
Benjamin Wolin
President and CEO |
SELL
Open market or private sale
|
Direct | 2,778 Reduced 3.82% |
$104,647
$37.67 p/Share
|
Jan 26
2021 |
|
INSM
|
Christine A Pellizzari
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,600 Reduced 1.81% |
$114,504
$44.04 p/Share
|
Jan 26
2021 |
|
LNN
|
Michael Christodolou |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 14.72% |
$290,220
$145.11 p/Share
|
Jan 26
2021 |
|
ADPT
|
Chad M Cohen
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 98.04% |
$3,204,500
$64.09 p/Share
|
Jan 26
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$977,550
$65.17 p/Share
|
Jan 26
2021 |
|
ALEC
|
Robert Paul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 27,308 Reduced 11.33% |
$491,544
$18.0 p/Share
|
Jan 26
2021 |
|
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 9,286 Reduced 0.33% |
$302,538
$32.58 p/Share
|
Jan 26
2021 |
|
BLNK
|
Donald Engel |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 18.18% |
$3,231,600
$53.86 p/Share
|
Jan 26
2021 |
|
CSTL
|
Daniel Bradbury
Director |
SELL
Open market or private sale
|
Indirect | 7,500 Reduced 0.39% |
$547,500
$73.0 p/Share
|
Jan 26
2021 |
|
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Indirect | 13,590 Reduced 0.76% |
$342,468
$25.2 p/Share
|
Jan 26
2021 |
|
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 10,319 Reduced 0.66% |
$260,039
$25.2 p/Share
|
Jan 26
2021 |
|
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Indirect | 10,200 Reduced 0.67% |
$257,040
$25.2 p/Share
|
Jan 26
2021 |
|
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Direct | 10,200 Reduced 0.35% |
$257,040
$25.2 p/Share
|
Jan 26
2021 |
|
SLQT
|
Robert Clay Grant
PRESIDENT |
SELL
Open market or private sale
|
Indirect | 3,400 Reduced 0.77% |
$85,646
$25.19 p/Share
|
Jan 26
2021 |
|
SLQT
|
Robert Clay Grant
PRESIDENT |
SELL
Open market or private sale
|
Direct | 10,215 Reduced 0.84% |
$257,316
$25.19 p/Share
|
Jan 26
2021 |
|
SLQT
|
Raffaele Sadun
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 10,296 Reduced 1.05% |
$259,356
$25.19 p/Share
|
Jan 26
2021 |